Literature DB >> 7887977

11B nuclear magnetic resonance studies of the interaction of borocaptate sodium with serum albumin.

P P Tang1, M P Schweizer, K M Bradshaw, W F Bauer.   

Abstract

The interaction between borocaptate sodium, Na2B12H11SH (BSH), and three types of serum albumin--bovine, human and dog (BSA, HSA and DSA)--has been investigated quantitatively using 11B NMR. The 11B chemical shifts and relaxation rates of BSH were studied with various concentrations of serum albumin (1-5%, w/v) at 295-310 degrees K. Correction of the longitudinal relaxation rate (R1) due to protein viscosity effects was accomplished. The corrected R1 values were analyzed mathematically using a saturation function and linear regression. The linewidths of 11B resonances, which are related to the spin-spin relaxation rates (R2), were also measured. The binding fractions (P), the number of binding sites (NBS), and the binding constants (Kb) of BSH at various concentrations of the three types of serum albumin (1-5%, w/v) were determined at 295 and 310 degrees K. We speculate that the nature of this interaction may be electrostatic.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887977     DOI: 10.1016/0006-2952(94)00529-u

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.

Authors:  C S Zuo; P V Prasad; P Busse; L Tang; R G Zamenhof
Journal:  Med Phys       Date:  1999-07       Impact factor: 4.071

2.  The role of boron MRI in boron neutron capture therapy.

Authors:  G W Kabalka; C Tang; P Bendel
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

Review 3.  Applications of heteronuclear NMR spectroscopy in biological and medicinal inorganic chemistry.

Authors:  Luca Ronconi; Peter J Sadler
Journal:  Coord Chem Rev       Date:  2008-01-26       Impact factor: 22.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.